Monte Rosa Therapeutics (GLUE) Insider Trading & Ownership $7.74 -0.74 (-8.73%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Monte Rosa Therapeutics (NASDAQ:GLUE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$11.58 M Get GLUE Insider Trade Alerts Want to know when executives and insiders are buying or selling Monte Rosa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GLUE Insider Buying and Selling by Quarter Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Monte Rosa Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/28/2024Versant Venture Capital Vi, L.Major ShareholderSell89,990$9.66$869,303.40 9/20/2024Versant Venture Capital Vi, L.Major ShareholderSell1,132,566$6.53$7,395,655.98 9/13/2024Versant Venture Capital Vi, L.Major ShareholderSell9,269$6.16$57,097.04 9/11/2024Versant Venture Capital Vi, L.Major ShareholderSell541,897$6.00$3,251,382.00 7/5/2024Edmund DunnInsiderSell1,610$3.83$6,166.30 (Data available from 1/1/2013 forward) GLUE Insider Trading Activity - Frequently Asked Questions Who is on Monte Rosa Therapeutics's Insider Roster? The list of insiders at Monte Rosa Therapeutics includes Edmund Dunn, and Versant Venture Capital Vi, L.. Learn more on insiders at GLUE. What percentage of Monte Rosa Therapeutics stock is owned by insiders? 6.50% of Monte Rosa Therapeutics stock is owned by insiders. Learn more on GLUE's insider holdings. Which Monte Rosa Therapeutics insiders have been selling company stock? The following insiders have sold GLUE shares in the last 24 months: Edmund Dunn ($6,166.30), and Versant Venture Capital Vi, L. ($11,573,438.42). How much insider selling is happening at Monte Rosa Therapeutics? Insiders have sold a total of 1,775,332 Monte Rosa Therapeutics shares in the last 24 months for a total of $11,579,604.72 sold. Monte Rosa Therapeutics Key ExecutivesDr. Markus Warmuth M.D. (Age 52)President, CEO & Director Compensation: $901.35kDr. Owen B. Wallace Ph.D. (Age 55)Chief Scientific Officer Compensation: $630.68kDr. Filip Janku M.D. (Age 49)Ph.D., Chief Medical Officer Compensation: $658.66kMs. Jennifer ChampouxChief People & Operations OfficerDr. Sharon Townson Ph.D. (Age 49)Chief Technology Officer Dr. John C. Castle Ph.D. (Age 52)Chief Data & Information Officer Mr. Andrew FunderburkSenior VP and Head of IR & Strategic FinanceMr. Philip Nickson J.D. (Age 45)Ph.D., General Counsel Mr. Magnus Walter DPHILSenior Vice President of Drug DiscoveryMr. Edmund Dunn (Age 58)Vice President & Corporate Controller 1 recent trades More Insider Trading Tools from MarketBeat Related Companies CCCC Insider Selling MCRB Insider Selling IVVD Insider Selling BLUE Insider Selling KRON Insider Selling NAMS Insider Selling HRMY Insider Selling WVE Insider Selling SYRE Insider Selling RXRX Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:GLUE) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monte Rosa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monte Rosa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLUE Stock Alerts